The Use of Cytomegalovirus Cell Mediated Immunity to Optimize the Duration of Letermovir Prophylaxis in Hematopoietic Cell Transplant Recipients
Clinical trial NCT06639854 · RECRUITING
Trial details
- NCT number
- NCT06639854
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-20
- Primary completion
- 2027-07-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.